Erck Stanley C - Insider Stock Trading - OpenInsider

CIK: 1342826 - Address: C/O Maxcyte, Inc., 9713 Key West Avenue, Suite 400, Rockville, MD 20850

13 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
P	%ret	2	1	11	4	6	13	29	83	87	37
P	%wins				91	70	80	80	80	70	78

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
5/15/18 11:13	5/14/18	NVAX	Novavax Inc	DE	Health	BioPrd	Biological Products, (No Diag	Erck Stanley C	MD	DO	P,CEO	P	165	1.65	0	100	44	328	D
11/13/17 08:13	11/9/17	NVAX	Novavax Inc	DE	Health	BioPrd	Biological Products, (No Diag	Erck Stanley C	MD	DO	P,CEO	P	113	1.13	0	100	78	228	D
5/11/17 10:29	5/11/17	NVAX	Novavax Inc	DE	Health	BioPrd	Biological Products, (No Diag	Erck Stanley C	MD	DO	P,CEO	P	42	0.8396	4	50	64	128	D	-90	-82	-44	-37	-35	1	1	12	12
2/1/16 17:30	1/31/16	NVAX	Novavax Inc	DE	Health	BioPrd	Biological Products, (No Diag	Erck Stanley C	MD	DO	CEO,P	P	9	4.38	33	2	2	103	D	-10	-34	-57	-30	-41	-27	-17	-9	-7	-4	-7	4	44	-73
8/4/15 16:43	7/31/15	NVAX	Novavax Inc	DE	Health	BioPrd	Biological Products, (No Diag	Erck Stanley C	MD	DO	CEO,P	P	7	2.28	33	3	3	101	D	352	184	57	51	22	0	1	2	2	-5	-10	-41	-58	-38
2/3/15 17:04	1/31/15	NVAX	Novavax Inc	DE	Health	BioPrd	Biological Products, (No Diag	Erck Stanley C	MD	DO	CEO,P	P	14	2.28	33	6	7	98	D	331	42	81	37	30	20	5	1	3	7	18	7	60	-36
8/4/14 15:11	7/31/14	NVAX	Novavax Inc	DE	Health	BioPrd	Biological Products, (No Diag	Erck Stanley C	MD	DO	CEO,P	P	15	2.28	14	7	8	92	D	95	59	-22	-1	-15	-5	-6	-5	3	2	14	32	81	184
3/25/14 14:08	3/25/14	NVAX	Novavax Inc	DE	Health	BioPrd	Biological Products, (No Diag	Erck Stanley C	MD	DO	CEO,P	P.a	43	4.27	33	10	13	85	D	215	91	32	-12	-29	-35	-24	-20	8	10	1	18	4	124
3/25/14 12:02	3/25/14	NVAX	Novavax Inc	DE	Health	BioPrd	Biological Products, (No Diag	Erck Stanley C	MD	DO	CEO,P	P	43	4.27	33	10	13	85	D	215	91	32	-12	-29	-35	-24	-20	8	10	1	18	4	124
2/4/14 09:19	1/31/14	NVAX	Novavax Inc	DE	Health	BioPrd	Biological Products, (No Diag	Erck Stanley C	MD	DO	P,CEO	P	27	2.29	32	12	19	75	D	251	194	99	71	13	-4	-17	-7	2	10	20	-18	-17	41
8/23/11 09:33	8/19/11	NVAX	Novavax Inc	DE	Health	BioPrd	Biological Products, (No Diag	Erck Stanley C	MD	DO	P,CEO	P	16	1.26	1	13	New	13	D	-74	-40	-43	-48	-37	-29	-7	-9	5	35	22	9	10	59
8/11/11 10:15	8/9/11	NVAX	Novavax Inc	DE	Health	BioPrd	Biological Products, (No Diag	Erck Stanley C	MD	DO	P,CEO	P.m	62	1.24	1	50		17	D	-74	-42	-45	-46	-38	-41	-32	-14	6	10	37	26	13	58
3/16/09 08:07	3/12/09	BCRX	Biocryst Pharmaceuticals Inc	DE	Health	BioPrd	Biological Products, (No Diag	Erck Stanley C	AL	D		P	49	1.22	0	40	New	40										2	-14	30	231	690	430

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact